Invivyd, Inc. (IVVD)
2.47
+0.04
(+1.65%)
USD |
NASDAQ |
Dec 31, 16:00
2.47
0.00 (0.00%)
After-Hours: 05:49
Invivyd Shareholders Equity (Quarterly): 93.07M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Amicus Therapeutics, Inc. | 230.42M |
| Relmada Therapeutics, Inc. | 9.466M |
| Arcellx, Inc. | 440.78M |
| ADMA Biologics, Inc. | 431.19M |
| Cidara Therapeutics, Inc. | 422.39M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 139.16M |
| Total Liabilities (Quarterly) | 46.09M |
| Debt to Equity Ratio | 0.0288 |
| Current Ratio | 2.467 |
| Net Debt Paydown Yield | -0.17% |